West Pharmaceutical Services Other Long-Term Assets 2010-2024 | WST

West Pharmaceutical Services other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • West Pharmaceutical Services other long-term assets for the quarter ending September 30, 2024 were $0.069B, a 78.61% increase year-over-year.
  • West Pharmaceutical Services other long-term assets for 2023 were $0.021B, a 44.53% decline from 2022.
  • West Pharmaceutical Services other long-term assets for 2022 were $0.038B, a 2.04% decline from 2021.
  • West Pharmaceutical Services other long-term assets for 2021 were $0.039B, a 67.52% increase from 2020.
West Pharmaceutical Services Annual Other Long-Term Assets
(Millions of US $)
2023 $21
2022 $38
2021 $39
2020 $23
2019 $25
2018 $21
2017 $23
2016 $21
2015 $26
2014 $28
2013 $24
2012 $25
2011 $29
2010 $23
2009 $19
West Pharmaceutical Services Quarterly Other Long-Term Assets
(Millions of US $)
2024-09-30 $69
2024-06-30 $50
2024-03-31 $19
2023-12-31 $21
2023-09-30 $39
2023-06-30 $40
2023-03-31 $37
2022-12-31 $38
2022-09-30 $53
2022-06-30 $49
2022-03-31 $41
2021-12-31 $39
2021-09-30 $32
2021-06-30 $26
2021-03-31 $25
2020-12-31 $23
2020-09-30 $22
2020-06-30 $21
2020-03-31 $22
2019-12-31 $25
2019-09-30 $20
2019-06-30 $20
2019-03-31 $26
2018-12-31 $21
2018-09-30 $22
2018-06-30 $22
2018-03-31 $22
2017-12-31 $23
2017-09-30 $17
2017-06-30 $16
2017-03-31 $22
2016-12-31 $21
2016-09-30 $23
2016-06-30 $23
2016-03-31 $24
2015-12-31 $26
2015-09-30 $26
2015-06-30 $27
2015-03-31 $27
2014-12-31 $28
2014-09-30 $23
2014-06-30 $24
2014-03-31 $24
2013-12-31 $24
2013-09-30 $26
2013-06-30 $25
2013-03-31 $24
2012-12-31 $25
2012-09-30 $25
2012-06-30 $25
2012-03-31 $29
2011-12-31 $29
2011-09-30 $29
2011-06-30 $30
2011-03-31 $23
2010-12-31 $23
2010-09-30 $20
2010-06-30 $22
2010-03-31 $19
2009-12-31 $19
2009-09-30 $20
2009-06-30 $21
2009-03-31 $20
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.239B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49